SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-151694
Filing Date
2024-05-31
Accepted
2024-05-31 16:01:11
Documents
7
Effectiveness Date
2024-05-31

Document Format Files

Seq Description Document Type Size
1 S-8 d831119ds8.htm S-8 59361
2 EX-4.3 d831119dex43.htm EX-4.3 56484
3 EX-4.4 d831119dex44.htm EX-4.4 28603
4 EX-5.1 d831119dex51.htm EX-5.1 14559
5 EX-23.1 d831119dex231.htm EX-23.1 1582
6 EX-FILING FEES d831119dexfilingfees.htm EX-FILING FEES 17597
7 GRAPHIC g831119g0530150459727.jpg GRAPHIC 3115
  Complete submission text file 0001193125-24-151694.txt   183666
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279862 | Film No.: 241009491
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)